501 related articles for article (PubMed ID: 19176871)
21. Compound 48/80 acts as a potent mucosal adjuvant for vaccination against Streptococcus pneumoniae infection in young mice.
Zeng L; Liu Y; Wang H; Liao P; Song Z; Gao S; Wu Y; Zhang X; Yin Y; Xu W
Vaccine; 2015 Feb; 33(8):1008-16. PubMed ID: 25595867
[TBL] [Abstract][Full Text] [Related]
22. Recombinant PhpA protein, a unique histidine motif-containing protein from Streptococcus pneumoniae, protects mice against intranasal pneumococcal challenge.
Zhang Y; Masi AW; Barniak V; Mountzouros K; Hostetter MK; Green BA
Infect Immun; 2001 Jun; 69(6):3827-36. PubMed ID: 11349048
[TBL] [Abstract][Full Text] [Related]
23. Development of 5-valent conjugate pneumococcal protein A - Capsular polysaccharide pneumococcal vaccine against invasive pneumococcal disease.
Meng C; Lin H; Huang J; Wang H; Cai Q; Fang L; Guo Y
Microb Pathog; 2009 Sep; 47(3):151-6. PubMed ID: 19467319
[TBL] [Abstract][Full Text] [Related]
24. Establishment of a Streptococcus pneumoniae nasopharyngeal colonization model in adult mice.
Wu HY; Virolainen A; Mathews B; King J; Russell MW; Briles DE
Microb Pathog; 1997 Sep; 23(3):127-37. PubMed ID: 9281471
[TBL] [Abstract][Full Text] [Related]
25. Intranasal immunization with heat-inactivated Streptococcus pneumoniae protects mice against systemic pneumococcal infection.
Hvalbye BK; Aaberge IS; Løvik M; Haneberg B
Infect Immun; 1999 Sep; 67(9):4320-5. PubMed ID: 10456869
[TBL] [Abstract][Full Text] [Related]
26. Mucosal delivery of a pneumococcal vaccine using Lactococcus lactis affords protection against respiratory infection.
Hanniffy SB; Carter AT; Hitchin E; Wells JM
J Infect Dis; 2007 Jan; 195(2):185-93. PubMed ID: 17191163
[TBL] [Abstract][Full Text] [Related]
27. Serum serotype-specific pneumococcal anticapsular immunoglobulin g concentrations after immunization with a 9-valent conjugate pneumococcal vaccine correlate with nasopharyngeal acquisition of pneumococcus.
Dagan R; Givon-Lavi N; Fraser D; Lipsitch M; Siber GR; Kohberger R
J Infect Dis; 2005 Aug; 192(3):367-76. PubMed ID: 15995949
[TBL] [Abstract][Full Text] [Related]
28. Reduction of nasal colonization of nontypeable Haemophilus influenzae following intranasal immunization with rLP4/rLP6/UspA2 proteins combined with aqueous formulation of RC529.
Mason KW; Zhu D; Scheuer CA; McMichael JC; Zlotnick GW; Green BA
Vaccine; 2004 Sep; 22(25-26):3449-56. PubMed ID: 15308371
[TBL] [Abstract][Full Text] [Related]
29. Enhanced protection against pneumococcal infection elicited by immunization with the combination of PspA, PspC, and ClpP.
Cao J; Chen D; Xu W; Chen T; Xu S; Luo J; Zhao Q; Liu B; Wang D; Zhang X; Shan Y; Yin Y
Vaccine; 2007 Jun; 25(27):4996-5005. PubMed ID: 17524530
[TBL] [Abstract][Full Text] [Related]
30. Oral immunization with recombinant Lactococcus lactis confers protection against respiratory pneumococcal infection.
Villena J; Medina M; Raya R; Alvarez S
Can J Microbiol; 2008 Oct; 54(10):845-53. PubMed ID: 18923553
[TBL] [Abstract][Full Text] [Related]
31. Immunization with polyamine transport protein PotD protects mice against systemic infection with Streptococcus pneumoniae.
Shah P; Swiatlo E
Infect Immun; 2006 Oct; 74(10):5888-92. PubMed ID: 16988268
[TBL] [Abstract][Full Text] [Related]
32. Transcutaneous immunization with pneumococcal surface protein A in mice.
Nagano H; Kawabata M; Sugita G; Tsuruhara A; Ohori J; Jimura T; Miyashita K; Kurono Y; Tomonaga K; Briles DE; Fujihashi K
Laryngoscope; 2018 Mar; 128(3):E91-E96. PubMed ID: 29226330
[TBL] [Abstract][Full Text] [Related]
33. Polyamine transporter potABCD is required for virulence of encapsulated but not nonencapsulated Streptococcus pneumoniae.
Pipkins HR; Bradshaw JL; Keller LE; Swiatlo E; McDaniel LS
PLoS One; 2017; 12(6):e0179159. PubMed ID: 28586394
[TBL] [Abstract][Full Text] [Related]
34. Study on specific mucosal immunity by intranasal immunization of outer membrane protein P6 of Haemophilus influenzae with cholera toxin B subunit.
Hotomi M; Yokoyama M; Kuki K; Togawa A; Yamanaka N
Acta Otolaryngol Suppl; 1996; 523():150-2. PubMed ID: 9082765
[TBL] [Abstract][Full Text] [Related]
35. A protein chimera including PspA in fusion with PotD is protective against invasive pneumococcal infection and reduces nasopharyngeal colonization in mice.
Converso TR; Goulart C; Darrieux M; Leite LCC
Vaccine; 2017 Sep; 35(38):5140-5147. PubMed ID: 28818567
[TBL] [Abstract][Full Text] [Related]
36. Mucosal vaccination with a multicomponent adenovirus-vectored vaccine protects against Streptococcus pneumoniae infection in the lung.
Arévalo MT; Xu Q; Paton JC; Hollingshead SK; Pichichero ME; Briles DE; Girgis N; Zeng M
FEMS Immunol Med Microbiol; 2009 Apr; 55(3):346-51. PubMed ID: 19291171
[TBL] [Abstract][Full Text] [Related]
37. Distinct approaches to investigate the importance of the murine 4-1BB 4-1BBL interaction in the antibody response to Streptococcus pneumoniae.
Moens L; Jeurissen A; Mittler RS; Wuyts G; Michiels G; Boon L; Ceuppens JL; Bossuyt X
J Leukoc Biol; 2007 Sep; 82(3):638-44. PubMed ID: 17550973
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of pneumococcal carriage in mice by subcutaneous immunization with peptides from the common surface protein pneumococcal surface adhesin a.
Johnson SE; Dykes JK; Jue DL; Sampson JS; Carlone GM; Ades EW
J Infect Dis; 2002 Feb; 185(4):489-96. PubMed ID: 11865401
[TBL] [Abstract][Full Text] [Related]
39. Protection against pneumococcal infection elicited by immunization with multiple pneumococcal heat shock proteins.
Cao J; Zhang X; Gong Y; Zhang Y; Cui Y; Lai X; Yin Y; Li M; Li D; Zhang L
Vaccine; 2013 Aug; 31(35):3564-71. PubMed ID: 23727004
[TBL] [Abstract][Full Text] [Related]
40. Intranasal Immunization with the Commensal
Shekhar S; Khan R; Schenck K; Petersen FC
Appl Environ Microbiol; 2019 Mar; 85(6):. PubMed ID: 30683742
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
